Trulieve Cannabis Corp. (CSE: TRUL & OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, will be opening the doors of a new dispensary on Friday, May 22nd. The latest Florida location marks a milestone 48 locations in the state of Florida and 50 nationwide for Trulieve.
Daytona Beach dispensary (CNW Group/Trulieve Cannabis Corp.)
Located on West International Speedway Boulevard, the dispensary supports the Company’s mission to expand and ensure safe, reliable patient access statewide. It also joins Trulieve’s 47 other dispensaries statewide, including in nearby Palm Coast, Orlando, and Titusville. At approximately 6,000 square feet, with 1,500 square feet of showroom space and 14 point-of-sale stations, the dispensary is one of the Company’s largest yet.
“We’ve spent the past couple months enacting proactive and protective changes throughout our dispensaries to ensure patients and staff feel comfortable, especially as the state begins the process of reopening. Our focus is on expanding access throughout the state of Florida, and providing patients a safe, reliable way to get the medication they rely on; with the uncertainty of the past several months, we have remained dedicated to patients and will continue to do so,” said Trulieve CEO Kim Rivers. “The Daytona Beach location is one we have been looking forward to opening for a while now and are thrilled to expand and improve access through the community. This dispensary will be one of our largest and has been modeled to accommodate for social distancing guidelines, both for the safety and comfort of patients and staff.”
Rivers added, “While patients are able to come and shop in-store, we also encourage patients to view our online catalog for ordering, offering both in-store pickup options and direct home delivery, available statewide.”
To commemorate the brand new dispensary, all patients — from those new to Trulieve to our strong Truliever community — will be eligible for a 25% in-store discount at the Daytona Beach location on the day of the opening.
As the state’s leading medical cannabis provider, Trulieve’s employees are experienced, knowledgeable, and eager to help patients. Trulieve encourages potential patients, as well as patients who are new to cannabis and our wide array of products, to connect with the staff in-store or through the online chat feature to learn more.
|WHAT:||Trulieve Daytona Beach Opening|
|WHERE:||812 W International Speedway Boulevard, Daytona Beach, Florida 32114|
|WHEN:||Friday, May 22, 2020, at 9:00 AM|
For our new dispensary opening, Trulieve will continue to make our entire catalog of products available for ordering online, with in-store pickup, curbside pickup, or home delivery options available. Additionally, to assist with CDC guidelines for social distancing and company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients, including limiting visitors to the dispensary to patients only and modifying store layouts to assist with social distancing. A full list of initiatives enacted by Trulieve in response to COVID-19 are available online at Trulieve.com.
In stores and online, patients will find Florida’s largest selection of THC and CBD products, available in a variety of delivery methods, including smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients, and convenient in-store pick-up at its 48 dispensaries in locations across the state from Pensacola to Key West.
The Office of Medical Marijuana Use recently announced the registry was approaching 340,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state’s overall volume, per the Florida Department of Health. There are nearly 2,500 registered ordering physicians in the State of Florida as well.
For more information, please visit www.Trulieve.com.
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
To learn more about Trulieve, visit www.Trulieve.com.